Eight CTSI core facilities offer services for investigators:
Broad expertise in the application of human-validated assessment measures of behavioral concomitants of disease or therapeutic interventions.
Services and training for induced Pluripotent Stem Cell (iPSC) derivation and related reprogramming technologies.
Clinician training through simulation in processes, drugs and devices in order to promote patient safety.
Collection, processing, storage and distribution services on remnant and prospective tissue samples.
Consultation and guidance in designing and performing genetics and pharmacogenetics studies, and targeted determination of genotypes on genomic DNA from biological samples.
Infrastructure and support to facilitate research and educational activities using Magnetic Resonance Imaging (MRI) technology, with particular emphasis on translational MRI research in humans.
Metabolomics services for clinical and basic science studies, including mass spectrometry, nuclear magnetic resonance and bioinformatics.
Promising compounds need assistance moving from the lab toward clinical trials, which generate the in vivo data needed for continued federal funding and licensing. The TDD core provides services and expertise in bioanalytical drug metabolism and preclinical pharmacokinetics in order to help faculty bridge this gap